Iodine 125 radioactive particles directed implantation to eliminate malignant tumors “without surgery to eliminate the malignant tumors in my body, I really did not think that Zhenjiang City Hospital of Traditional Chinese Medicine Interventional Section has such a skill,” this is a malignant tumor patients recently said the heart. Lao Wang is 75 years old this year, suffering from advanced pancreatic cancer, intolerable pain, has lost the opportunity to operate, and conventional radiotherapy for pancreatic cancer and insensitive, the family for the old king’s disease around the doctor, but there is no other good way, just when at a loss, a chance through the introduction of other people to find the Zhenjiang City Hospital of Traditional Chinese Medicine Interventional Department Zhu Yongqiang director, Zhu director of the serious assessment of the condition, decided to give the old king of the line of iodine-125 radioactive particle implantation treatment. After nearly two hours of surgery, a radioactive particle with gamma rays was buried into the tumor, and the tumor was irradiated at a close distance, and now two months later, the pain of the old king has not only been relieved, but the lumps have also shrunk significantly. Director Zhu said that the Interventional Department of Zhenjiang Hospital of Traditional Chinese Medicine is currently the only department in the city that has been evaluated by experts in the province and has been awarded the qualification of using Iodine 125 radioactive particle implantation for the treatment of malignant tumors, and has successfully diagnosed and treated hundreds of patients since the development of this technology, which has prolonged the survival time of these patients with advanced tumors and improved their quality of life. Intertissue implantation of radioactive particles is a therapeutic method for local control of malignant tumors. The micro radioactive seed source is implanted into the tumor tissue, which continuously emits low-energy gamma rays, and through the continuous low-dose radiation effect, the tumor tissue suffers the maximum degree of killing and injuring, while the normal tissues are not damaged or only slightly damaged, which cannot be done by external radiotherapy. The main indications include: 1, advanced tumors in chest and abdomen (lung cancer, liver cancer, pancreatic cancer, bile duct cancer, ovarian cancer, cervical cancer, etc.), tumors without surgery, metastatic tumors, tumors with poor effect of radiotherapy and tumors that can not tolerate surgery. 2, superficial tumors of head and neck, trunk and limbs and lymph node metastasis. Radioactive particle brachytherapy technology has been generally valued by scholars at home and abroad for improving the survival rate and local control rate of lesions as well as improving the quality of life, and its effects of inhibiting tumor growth, relieving pain and improving the quality of life have been generally recognized. Radioactive particle implantation brachytherapy has a broad clinical application prospect due to its good efficacy, low damage to normal tissues, uniform dose distribution in tumor tissues, and minimally invasive, especially for tumors that are difficult to be resected by surgery and recurring after surgery and radiotherapy, radioactive particle brachytherapy is undoubtedly a more reasonable and effective treatment pathway. Preoperative pancreatic cancer Intraoperative particle implantation Postoperative particle implantation